Global Erectile Dysfunction Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Erectile Dysfunction market size was valued at US$ 6084 million in 2024 and is forecast to a readjusted size of USD 9721 million by 2031 with a CAGR of 6.9% during review period.

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

The erectile dysfunction (ED) drug market is experiencing significant growth. The main drivers of market growth include the increase in the elderly population, increased awareness of ED, innovation in treatment methods, and favorable reimbursement policies.

The prevalence of ED is rising globally, with an estimated 15% of men affected by ED each year and expected to affect 320 million people by 2025. The incidence of ED increases with age, and the growth of the elderly population is one of the key factors driving the growth of the ED drugs market.

Technological advancements such as new drug development, innovations in drug delivery systems such as sublingual tablets, topical creams, and nasal sprays are also driving market growth. Additionally, the rise of telemedicine services is changing how ED treatment is obtained.

The market is highly concentrated, with major players including Bayer, Eli Lilly, Pfizer, Teva and other companies. These companies strengthen their market positions by launching new drugs, expanding product portfolios and market coverage.

In terms of products, sildenafil (Viagra) held the largest market share in 2023, followed by tadalafil (Cialis), vardenafil (Levitra), and avanafil (Stendra).

In terms of route of administration, oral drugs accounted for the largest market share in 2023, and other routes, including topical and intraurethral delivery, are expected to grow at the fastest rate.

From a regional perspective, North America is the largest market, accounting for more than 40% of the market share, followed by Asia Pacific and Europe.

Overall, the ED drugs market is driven by several factors, including increasing geriatric population, changing lifestyles, technological advancements, and rising awareness about ED treatments. The market is expected to continue to expand as new drugs and new treatment modalities are developed.

This report is a detailed and comprehensive analysis for global Erectile Dysfunction market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Erectile Dysfunction market size and forecasts, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2020-2031

Global Erectile Dysfunction market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2020-2031

Global Erectile Dysfunction market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million Pill), and average selling prices (USD/Pill), 2020-2031

Global Erectile Dysfunction market shares of main players, shipments in revenue ($ Million), sales quantity (Million Pill), and ASP (USD/Pill), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Erectile Dysfunction

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Erectile Dysfunction market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Pfizer, Bayer, BaiYunShan General Factory, S.K. Chemicals, Teva Pharma, Dong-A ST, Petros Pharmaceuticals, Seoul Pharma, Yabang Pharmacy, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Erectile Dysfunction market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Sildenafil
Tadalafil
Others

Market segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

Major players covered
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Erectile Dysfunction product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Erectile Dysfunction, with price, sales quantity, revenue, and global market share of Erectile Dysfunction from 2020 to 2025.

Chapter 3, the Erectile Dysfunction competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Erectile Dysfunction breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Erectile Dysfunction market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Erectile Dysfunction.

Chapter 14 and 15, to describe Erectile Dysfunction sales channel, distributors, customers, research findings and conclusion.